Zhao Xianghui, Lv Peiying, Cai Zixing, Dong Jun, Chen Wenxiang, Sun Liang, Yang Ruiyue
The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology of National Health Commission, Beijing, China.
Front Immunol. 2025 Jun 2;16:1579924. doi: 10.3389/fimmu.2025.1579924. eCollection 2025.
CD38, a glycoprotein with a single transmembrane structure, is extensively found in erythrocytes, immune cells, and endothelial cells. Primarily located on cell membranes, it plays a critical role in metabolizing nicotinamide adenine dinucleotide (NAD), thereby maintaining NAD homeostasis . As a vital coenzyme, NAD is involved in numerous biological processes, including energy metabolism, apoptosis, and DNA repair. CD38, as a major NAD-depleting enzyme, is pivotal in regulating intracellular NAD levels and various physiological processes. Given its significance, understanding the function of CD38 and its implications in aging and age-related diseases is crucial for elucidating disease pathogenesis and developing therapeutic strategies.
This study conducted a bibliometric analysis to explore recent research trends and advancements in the field of CD38. Research articles were retrieved from the Web of Science database, followed by a bibliometric assessment using CiteSpace and VOSviewer to visualize key publication trends, contributions by countries and institutions, and keyword distributions. Based on the bibliometric analysis, key insights were synthesized to elucidate the role of CD38 in aging and age-related diseases, its underlying mechanisms, and its applications in clinical evaluation, detection methods, interventions, and therapeutic targets.
The bibliometric analysis revealed an exponential increase in the number of published articles over time, with the United States and China emerging as the leading research hubs. The predominant keywords included 'CD38' and 'blood-related disorders'. Furthermore, key findings highlighted the critical role of CD38 in aging and age-related diseases, emphasizing its mechanisms in NAD metabolism and its potential as a therapeutic target. Moreover, current applications of CD38 in clinical evaluation and detection methods were discussed, showcasing its growing importance in biomedical research.
This study underscores the growing interest in CD38 research, particularly its role in aging and age-related diseases. The findings highlight the significance of CD38 in maintaining NAD homeostasis and its potential as a therapeutic target. The exponential growth in publications and the dominance of the United States and China in this field reflect the global importance of CD38 research. Future studies should further explore the mechanistic insights and clinical applications of CD38 to advance therapeutic strategies for age-related diseases.
CD38是一种具有单一跨膜结构的糖蛋白,广泛存在于红细胞、免疫细胞和内皮细胞中。它主要位于细胞膜上,在烟酰胺腺嘌呤二核苷酸(NAD)代谢中起关键作用,从而维持NAD的体内平衡。作为一种重要的辅酶,NAD参与众多生物过程,包括能量代谢、细胞凋亡和DNA修复。CD38作为一种主要的消耗NAD的酶,在调节细胞内NAD水平和各种生理过程中起着关键作用。鉴于其重要性,了解CD38的功能及其在衰老和与年龄相关疾病中的意义对于阐明疾病发病机制和制定治疗策略至关重要。
本研究进行了文献计量分析,以探索CD38领域的最新研究趋势和进展。从科学网数据库中检索研究文章,然后使用CiteSpace和VOSviewer进行文献计量评估,以可视化关键的发表趋势、国家和机构的贡献以及关键词分布。基于文献计量分析,综合关键见解以阐明CD38在衰老和与年龄相关疾病中的作用、其潜在机制以及在临床评估、检测方法、干预措施和治疗靶点方面的应用。
文献计量分析显示,随着时间的推移,已发表文章的数量呈指数增长,美国和中国成为主要的研究中心。主要关键词包括“CD38”和“血液相关疾病”。此外,关键发现突出了CD38在衰老和与年龄相关疾病中的关键作用,强调了其在NAD代谢中的机制及其作为治疗靶点的潜力。此外,还讨论了CD38目前在临床评估和检测方法中的应用,展示了其在生物医学研究中日益重要的地位。
本研究强调了对CD38研究的兴趣日益增加,特别是其在衰老和与年龄相关疾病中的作用。研究结果突出了CD38在维持NAD体内平衡中的重要性及其作为治疗靶点的潜力。出版物的指数增长以及美国和中国在该领域的主导地位反映了CD38研究的全球重要性。未来的研究应进一步探索CD38的机制见解和临床应用,以推进与年龄相关疾病的治疗策略。